Pesquisas alternativas:
development type » development types (Expandir a Pesquisa), development time (Expandir a Pesquisa), development three (Expandir a Pesquisa)
doses developing » does developing (Expandir a Pesquisa), cases developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa)
developing type » developing novel (Expandir a Pesquisa)
de development » de developpment (Expandir a Pesquisa), de developpement (Expandir a Pesquisa), line development (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
development type » development types (Expandir a Pesquisa), development time (Expandir a Pesquisa), development three (Expandir a Pesquisa)
doses developing » does developing (Expandir a Pesquisa), cases developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa)
developing type » developing novel (Expandir a Pesquisa)
de development » de developpment (Expandir a Pesquisa), de developpement (Expandir a Pesquisa), line development (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Tácio de Mendonça Lima, Millena Padela da Silva, Luan Donato Silva Luz, Thais Cristina Amorim Estevão Soares, Etielle Silvestre Dantas, Gabriela Felix Teixeira, Rafael Henrique de Souza Costa, Sérgio Henrique Monte Santo Andrade
Publicado em 2022-03-01
Assuntos:
“...Drug dosage calculation...”Publicado em 2022-03-01
Obter o texto integral
Artigo
2
“... termination of drug development or withdrawal of drugs from the market. Management of such interactions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Johnson, Amy J., Lucas, David M., Muthusamy, Natarajan, Smith, Lisa L., Edwards, Ryan B., De Lay, Michael D., Croce, Carlo M., Grever, Michael R., Byrd, John C.
Publicado em 2006
“...Drug development in human chronic lymphocytic leukemia (CLL) has been limited by lack of a suitable...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... development of skin lesions, mortality, and latency was related to the dose of ACV-resistant virus used...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“...Background. Drug resistance development in the human immunodeficiency virus (HIV)-infected...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... for systemic adenovirus infections rely on a nonhuman adenovirus. We established mouse adenovirus type 1 (MAV-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“.... In this observational study we investigated developmental milestones of fetal behavior during the pregnancy of women...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Demonceau, Jenny, Ruppar, Todd, Kristanto, Paulus, Hughes, Dyfrig A., Fargher, Emily, Kardas, Przemyslaw, De Geest, Sabina, Dobbels, Fabienne, Lewek, Pawel, Urquhart, John, Vrijens, Bernard
Publicado em 2013
“... of strategies and components thereof that improve implementation of the prescribed drug dosing regimen...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Roberta Simone Andreazza, Mauro Silveira De Castro, Patrícia Sippel Köche, Isabela Heineck
Publicado em 2011-12-01
Assuntos:
“...Servicio de urgencias...”Publicado em 2011-12-01
Obter o texto integral
Artigo
10
“...<p>Abstract</p> <p>Background</p> <p>Type 2 diabetes is a risk factor for Alzheimer's disease (AD...”
Obter o texto integral
Obter o texto integral
Artigo
11
Por Wang, Jin, Lee, Jean, Burns, Daniel, Doherty, David, Brunner, Laura, Peterson, Mark, DeSilva, Binodh
Publicado em 2009
“...Biomarkers are used to study drug effects, exposure–response relationships, and facilitate early...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por De Clercq, E
Publicado em 1997
“...-bromovinyl)-2'-deoxyuridine (BVDU [brivudin]) for the therapy of herpes simplex virus type 1 and varicella...”Publicado em 1997
Obter o texto integral
Obter o texto integral
Artigo
13
Por Fonseca, Alyne de Melo, Sousa, Valéria Pereira de, Carmo, Flávia Almada do, Universidade Federal do Rio de Janeiro.
Publicado em 2018
“... viabilidade e proliferação celulares de maneira dose-dependente, principalmente nas culturas de células SK-MEL...”Publicado em 2018
Obter o texto integral
Livro
14
Por Wang, Wei-Peng, Ho, Pui Yan, Chen, Qiu-Xia, Addepalli, Balasubrahmanyam, Limbach, Patrick A., Li, Mei-Mei, Wu, Wen-Juan, Jilek, Joseph L., Qiu, Jing-Xin, Zhang, Hong-Jian, Li, Tianhong, Wun, Theodore, White, Ralph DeVere, Lam, Kit S., Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
16
Por Javier J.L. Rico, Vanessa M. Castilho, Sílvio Morato, Manoel Jorge Nobre
Publicado no Psychology & Neuroscience (2009)
Assuntos:
“...Drug abuse...”Publicado no Psychology & Neuroscience (2009)
Obter o texto integral
Artigo
17
Por Bryan T Mayer, Allan C deCamp, Yunda Huang, Joshua T Schiffer, Raphael Gottardo, Peter B Gilbert, Daniel B Reeves
Publicado em 2022-04-01
“... the composition, or dose ratio, of combination bNAb therapies for future clinical studies. We developed a model...”Publicado em 2022-04-01
Obter o texto integral
Artigo
18
Por Walter Oleschko Arruda, María Belén Montú, Marcelo de Souza R. de Oliveira, Ricardo Ramina
Publicado em 2005-06-01
“...Arquivos de Neuro-Psiquiatria...”Publicado em 2005-06-01
Obter o texto integral
Artigo
19
Por Yao, Yihong, Higgs, Brandon W., Morehouse, Chris, de los Reyes, Melissa, Trigona, Wendy, Brohawn, Philip, White, Wendy, Zhang, Jianliang, White, Barbara, Coyle, Anthony J., Kiener, Peter A., Jallal, Bahija
Publicado em 2009
“...To identify potential pharmacodynamic biomarkers to guide dose selection in clinical trials using...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... virus type 1 [ID50 (mean inhibitory dose), 0.004-0.02 microgram/ml]. Both (E)-5-(2-bromovinyl)-dUrd...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo